 |
|
Impact of Valve Surgery on 6-Month Mortality in Adults With Complicated, Left-Sided Native Valve Endocarditis
A Propensity Analysis
Holenarasipur R. Vikram, MD;
Joan Buenconsejo, MPH;
Rodrigo Hasbun, MD;
Vincent J. Quagliarello, MD
JAMA. 2003;290:3207-3214.
Context Complicated, left-sided native valve endocarditis causes significant morbidity and mortality in adults. The presumed benefits of valve surgery remain unproven due to lack of randomized controlled trials.
Objective To determine whether valve surgery is associated with reduced mortality in adults with complicated, left-sided native valve endocarditis.
Design and Setting Retrospective, observational cohort study conducted from January 1990 to January 2000 at 7 Connecticut hospitals. Propensity analyses were used to control for bias in treatment assignment and prognostic imbalances.
Patients Of the 513 adults with complicated, left-sided native valve endocarditis, 230 (45%) underwent valve surgery and 283 (55%) received medical therapy alone.
Main Outcome Measure All-cause mortality at 6 months after baseline.
Results In the 6-month period after baseline, 131 patients (26%) died. In unadjusted analyses, valve surgery was associated with reduced mortality (16% vs 33%; hazard ratio [HR], 0.43; 95% confidence interval [CI], 0.29-0.63; P<.001). After adjustment for baseline variables associated with mortality (including hospital site, comorbidity, congestive heart failure, microbial etiology, immunocompromised state, abnormal mental status, and refractory infection), valve surgery remained associated with reduced mortality (adjusted HR, 0.35; 95% CI, 0.23-0.54; P<.02). In further analyses of 218 patients matched by propensity scores, valve surgery remained associated with reduced mortality (15% vs 28%; HR, 0.45; 95% CI, 0.23-0.86; P = .01). After additional adjustment for variables that contribute to heterogeneity and confounding within the propensity-matched group, surgical therapy remained significantly associated with a lower mortality (HR, 0.40; 95% CI, 0.18-0.91; P = .03). In this propensity-matched group, patients with moderate to severe congestive heart failure showed the greatest reduction in mortality with valve surgery (14% vs 51%; HR, 0.22; 95% CI, 0.09-0.53; P = .001).
Conclusions Valve surgery for patients with complicated, left-sided native valve endocarditis was independently associated with reduced 6-month mortality after adjustment for both baseline variables associated with the propensity to undergo valve surgery and baseline variables associated with mortality. The reduced mortality was particularly evident among patients with moderate to severe congestive heart failure.
Author Affiliations: Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn. Dr Vikram is now with Infectious Disease Section, Hospital of St Raphael, New Haven, Conn. Ms Buenconsejo is now with Yale University School of Epidemiology and Public Health, New Haven, Conn. Dr Hasbun is now with Infectious Disease Section, Tulane University School of Medicine, New Orleans, La.
RELATED ARTICLE
Evaluating and Optimizing Outcomes of Surgery for Endocarditis
David T. Durack
JAMA. 2003;290(24):3250-3251.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Surgical therapy in patients with active infective endocarditis: seven-year single centre experience in a subgroup of 255 patients treated with the Shelhigh(R) stentless bioprosthesis
Musci et al.
Eur. J. Cardiothorac. Surg. 2008;34:410-417.
ABSTRACT
| FULL TEXT
The association between the timing of valve surgery and 6-month mortality in left-sided infective endocarditis
Tleyjeh et al.
Heart 2008;94:892-896.
ABSTRACT
| FULL TEXT
Echocardiographic risk stratification for early surgery with endocarditis: a cost-effectiveness analysis
Liao et al.
Heart 2008;94:e18-e18.
ABSTRACT
| FULL TEXT
Surgical treatment of right-sided active infective endocarditis with or without involvement of the left heart: 20-year single center experience
Musci et al.
Eur. J. Cardiothorac. Surg. 2007;32:118-125.
ABSTRACT
| FULL TEXT
Epidemiology and Clinical Outcomes of Infective Endocarditis in Hemodialysis Patients
Kamalakannan et al.
Ann. Thorac. Surg. 2007;83:2081-2086.
ABSTRACT
| FULL TEXT
The Impact of Valve Surgery on 6-Month Mortality in Left-Sided Infective Endocarditis
Tleyjeh et al.
Circulation 2007;115:1721-1728.
ABSTRACT
| FULL TEXT
Predictors of Death and Impact of Surgery in Staphylococcus aureus Infective Endocarditis
Remadi et al.
Ann. Thorac. Surg. 2007;83:1295-1302.
ABSTRACT
| FULL TEXT
Contemporary Clinical Profile and Outcome of Prosthetic Valve Endocarditis
Wang et al.
JAMA 2007;297:1354-1361.
ABSTRACT
| FULL TEXT
Diabetes mellitus and infective endocarditis: the insulin factor in patient morbidity and mortality
Duval et al.
Eur Heart J 2007;28:59-64.
ABSTRACT
| FULL TEXT
The changing face of infective endocarditis.
Cecchi et al.
Heart 2006;92:1365-1366.
ABSTRACT
| FULL TEXT
Management of infective endocarditis
Habib
Heart 2006;92:124-130.
FULL TEXT
Surgical Treatment of Mitral Valve Endocarditis in North America
Gammie et al.
Ann. Thorac. Surg. 2005;80:2199-2204.
ABSTRACT
| FULL TEXT
Infective Endocarditis: Global, Regional, and Future Perspectives
Quagliarello
JAMA 2005;293:3061-3062.
FULL TEXT
Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America
Baddour et al.
Circulation 2005;111:e394-e434.
ABSTRACT
| FULL TEXT
The year in valvular heart disease
Rahimtoola
J Am Coll Cardiol 2005;45:111-122.
FULL TEXT
Benefits of Surgery for Complicated Endocarditis
JWatch Infect. Diseases 2004;2004:9-9.
FULL TEXT
Evaluating and Optimizing Outcomes of Surgery for Endocarditis
Durack
JAMA 2003;290:3250-3251.
FULL TEXT
|
